Detalhe da pesquisa
1.
First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 13(11): 1161-70, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23078958
2.
Mental Health Outcomes Among British Healthcare Workers-Lessons From the First Wave of the Covid-19 Pandemic.
J Occup Environ Med
; 63(8): e549-e555, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34190508
3.
The clinical role of VeriStrat testing in patients with advanced non-small cell lung cancer considered unfit for first-line platinum-based chemotherapy.
Eur J Cancer
; 120: 86-96, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31499384
4.
Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial.
Eur J Cancer
; 83: 302-312, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28780466
5.
Thymidylate synthase expression and outcome of patients receiving pemetrexed for advanced nonsquamous non-small-cell lung cancer in a prospective blinded assessment phase II clinical trial.
J Thorac Oncol
; 8(7): 930-9, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23722170
6.
Radical radiotherapy with or without gemcitabine in patients with early stage medically inoperable non-small cell lung cancer.
Lung Cancer
; 77(3): 532-6, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22672970
7.
Use of an ATP-based chemosensitivity assay to design new combinations of high-concentration doxorubicin with other drugs for recurrent ovarian cancer.
Anticancer Drugs
; 13(6): 625-30, 2002 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12172508